These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
425 related articles for article (PubMed ID: 29486615)
1. First data on in vitro fertilization and blastocyst formation after intraovarian injection of calcium gluconate-activated autologous platelet rich plasma. Sills ES; Rickers NS; Li X; Palermo GD Gynecol Endocrinol; 2018 Sep; 34(9):756-760. PubMed ID: 29486615 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of intra-ovarian injection of autologous platelet-rich plasma in women with poor responders: a systematic review and meta-analysis. Vahabi Dastjerdi M; Sheibani S; Taheri M; Hezarcheshmeh FK; Jahangirian J; Jazayeri M; Hosseinirad H; Doohandeh T; Valizadeh R Arch Gynecol Obstet; 2024 Jun; 309(6):2323-2338. PubMed ID: 38589612 [TBL] [Abstract][Full Text] [Related]
3. Effects of intraovarian injection of autologous platelet rich plasma on ovarian reserve and IVF outcome parameters in women with primary ovarian insufficiency. Cakiroglu Y; Saltik A; Yuceturk A; Karaosmanoglu O; Kopuk SY; Scott RT; Tiras B; Seli E Aging (Albany NY); 2020 Jun; 12(11):10211-10222. PubMed ID: 32507764 [TBL] [Abstract][Full Text] [Related]
4. Intraovarian platelet-rich plasma injection and IVF outcomes in patients with poor ovarian response: a double-blind randomized controlled trial. Barrenetxea G; Celis R; Barrenetxea J; Martínez E; De Las Heras M; Gómez O; Aguirre O Hum Reprod; 2024 Apr; 39(4):760-769. PubMed ID: 38423539 [TBL] [Abstract][Full Text] [Related]
5. Effect of intraovarian platelet-rich plasma injection on IVF outcomes in women with poor ovarian response: the PROVA randomized controlled trial. Herlihy NS; Cakiroglu Y; Whitehead C; Reig A; Tiras B; Scott RT; Seli E Hum Reprod; 2024 May; ():. PubMed ID: 38725194 [TBL] [Abstract][Full Text] [Related]
6. Ovarian reserve parameters and IVF outcomes in 510 women with poor ovarian response (POR) treated with intraovarian injection of autologous platelet rich plasma (PRP). Cakiroglu Y; Yuceturk A; Karaosmanoglu O; Kopuk SY; Korun ZEU; Herlihy N; Scott RT; Tiras B; Seli E Aging (Albany NY); 2022 Mar; 14(6):2513-2523. PubMed ID: 35320118 [TBL] [Abstract][Full Text] [Related]
7. Intra-ovarian infusion of autologous platelet-rich plasma in women with poor ovarian reserve: A before and after study. Hosseinisadat R; Farsi Nejad A; Mohammadi F Eur J Obstet Gynecol Reprod Biol; 2023 Jan; 280():60-63. PubMed ID: 36403398 [TBL] [Abstract][Full Text] [Related]
8. Intraovarian platelet-rich plasma injection in poor responders. Devenutto LM; Valzacchi GR; Ercolano M; Etchegoyen O JBRA Assist Reprod; 2024 Aug; 28(3):450-456. PubMed ID: 38838163 [TBL] [Abstract][Full Text] [Related]
9. The effect of ovarian injection of autologous platelet rich plasma in patients with poor ovarian responder: a systematic review and meta-analysis. Li X; Liu H; Lin G; Xu L Front Endocrinol (Lausanne); 2023; 14():1292168. PubMed ID: 38155954 [TBL] [Abstract][Full Text] [Related]
10. A report on three live births in women with poor ovarian response following intra-ovarian injection of platelet-rich plasma (PRP). Farimani M; Heshmati S; Poorolajal J; Bahmanzadeh M Mol Biol Rep; 2019 Apr; 46(2):1611-1616. PubMed ID: 30725347 [TBL] [Abstract][Full Text] [Related]
11. Platelet-rich plasma (PRP) treatment of the ovaries significantly improves fertility parameters and reproductive outcomes in diminished ovarian reserve patients: a systematic review and meta-analysis. Éliás M; Kónya M; Kekk Z; Turan C; das Virgens IPA; Tóth R; Keszthelyi M; Hegyi P; Várbíró S; Sipos M J Ovarian Res; 2024 May; 17(1):104. PubMed ID: 38760869 [TBL] [Abstract][Full Text] [Related]
12. The use of autologous platelet-rich plasma (PRP) versus no intervention in women with low ovarian reserve undergoing fertility treatment: a non-randomized interventional study. Melo P; Navarro C; Jones C; Coward K; Coleman L J Assist Reprod Genet; 2020 Apr; 37(4):855-863. PubMed ID: 32030554 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of intra-ovarian platelet-rich plasma administration on oocytes-dependent variables in patients with poor ovarian response: A retrospective study according to the POSEIDON criteria. Farimani M; Nazari A; Mohammadi S; Anvari Aliabad R Reprod Biol Endocrinol; 2021 Sep; 19(1):137. PubMed ID: 34496887 [TBL] [Abstract][Full Text] [Related]
14. Preliminary report of intraovarian injections of autologous platelet-rich plasma (PRP) in extremely poor prognosis patients with only oocyte donation as alternative: a prospective cohort study. Barad DH; Albertini DF; Molinari E; Gleicher N Hum Reprod Open; 2022; 2022(3):hoac027. PubMed ID: 35795849 [TBL] [Abstract][Full Text] [Related]
15. The efficacy of platelet rich plasma on women with poor ovarian response: a systematic review and meta-analysis. Wu L; Su F; Luo P; Dong Q; Ma M; Ye G Platelets; 2024 Dec; 35(1):2292612. PubMed ID: 38214306 [TBL] [Abstract][Full Text] [Related]
16. Effects of Intraovarian Injection of Autologous Platelet-Rich Plasma on Ovarian Rejuvenation in Poor Responders and Women with Primary Ovarian Insufficiency. Aflatoonian A; Lotfi M; Saeed L; Tabibnejad N Reprod Sci; 2021 Jul; 28(7):2050-2059. PubMed ID: 33683669 [TBL] [Abstract][Full Text] [Related]
17. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation]. Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561 [TBL] [Abstract][Full Text] [Related]
18. A narrative review of platelet-rich plasma (PRP) in reproductive medicine. Sharara FI; Lelea LL; Rahman S; Klebanoff JS; Moawad GN J Assist Reprod Genet; 2021 May; 38(5):1003-1012. PubMed ID: 33723748 [TBL] [Abstract][Full Text] [Related]
19. Initiation of ovarian stimulation independent of the menstrual cycle: a case-control study. Buendgen NK; Schultze-Mosgau A; Cordes T; Diedrich K; Griesinger G Arch Gynecol Obstet; 2013 Oct; 288(4):901-4. PubMed ID: 23545834 [TBL] [Abstract][Full Text] [Related]
20. Single intraovarian dose of stem cell- and platelet-secreted factors mitigates age-related ovarian infertility in a murine model. Marchante M; Buigues A; Ramirez-Martin N; Martinez J; Pellicer N; Pellicer A; Herraiz S Am J Obstet Gynecol; 2023 May; 228(5):561.e1-561.e17. PubMed ID: 36706857 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]